Primal Peptides
270 subscribers
398 photos
77 videos
3 files
335 links
๐Ÿงช Weight Loss, Fat Burning, Energy Boosting, Reverse-Aging, Biohacking

Microdosing GLP-1s & Peptides, Exclusive Discounts & Sales, High Protein Recipes, Quality Research, Motivation & Support ๐Ÿ’ž
Download Telegram
๐Ÿ‚ Fall research focus: LL-37 for seasonal immune support studies
LL-37 is a natural protein that research subjects make in their bodies to fight germs. As cold and flu season starts, scientists are studying how LL-37 might help people who get sick often.

Research Uses:
For people who get sick often during seasonal changes, LL-37 studies suggest it might help with:
> Infections with tough bacterial slime layers
> Seasonal breathing problems
> Healing cuts and wounds
> Protecting against bacterial toxins

What Scientists Foundโ€ฆ

Breaks Down Germ Shields:
LL-37 stopped bacteria from making protective slime layers at very low doses - much less than what's needed to kill the bacteria directly. This worked against tough bacteria like Pseudomonas. Tests showed LL-37 killed over 99% of Staph bacteria living in these slime layers, working better than regular antibiotics.


Fights Many Types of Germs:
Studies show LL-37 works against bacteria, viruses, and fungus by breaking their outer walls and helping the immune system. It works even better when mixed with other antibiotics against dangerous bacteria like E. coli.


Neutralizes Harmful Toxins:
LL-37 can grab onto and stop bacterial toxins that make people very sick. In animal studies, this prevented death from toxin poisoning. Special cells designed to make LL-37 were better at stopping toxins and preventing organ damage in sick animals.


Helps Healing:
Lab tests show LL-37 makes skin cells move and grow faster. In diabetic mice with wounds, LL-37 helped skin grow back and form healthy tissue. When mice had infected cuts, LL-37 treatment helped skin heal faster with better blood vessel growth.


How It Works:
LL-37 forms tiny tunnels in bacterial walls that let water in and kill the germs. Scientists can watch bacteria die under microscopes. LL-37 levels go up most at 48 hours after injury, then drop when healing is done.

Research use only ๐Ÿ”ฌ

Further reading:
https://pmc.ncbi.nlm.nih.gov/articles/PMC8227053/ https://pubmed.ncbi.nlm.nih.gov/18591225/ https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0216676 https://pmc.ncbi.nlm.nih.gov/articles/PMC2519444/ https://pubmed.ncbi.nlm.nih.gov/17805349/ https://www.mdpi.com/2079-6382/10/10/1210 https://pmc.ncbi.nlm.nih.gov/articles/PMC3699762/ https://www.nature.com/articles/s41598-020-74401-5 https://pubmed.ncbi.nlm.nih.gov/12603850/ https://link.springer.com/article/10.1007/s00005-009-0057-2
Media is too big
VIEW IN TELEGRAM
๐Ÿงฎ Did you check out the free PeptideCalc beta app yet?

Feel more confident in your research calculations and protocols.

Access the beta: https://tinyurl.com/mry8a5kw

Perfect for serious researchers who want precision in their work ๐Ÿ”ฌ

Research use only. Not medical advice.
This media is not supported in your browser
VIEW IN TELEGRAM
Life's too short for perfection. I'm here for the 80/20 - biohacking and optimizing what matters what matters, loosening my grip on what doesn't.

I share what's genuinely moved the needle for me, not because it's "perfect," but because it's worked. Take what resonates, leave the rest.

What's one thing you've stopped trying to perfect that's actually made your life better? ๐Ÿ‘‡
Biostrategix just dropped the most powerful GLP1 Blend Ever: Tirz-Reta. ๐Ÿ˜

Available now AND on sale AND stackable with my code PRIMALSAM

https://collabs.shop/5gbvvn 

Limited Supplies, Don't Miss It! 

*Research peptides are for research use only, and not specified for human, animal, or in-vivo use.
๐Ÿง  Does your RS ever walk into a room and forget why theyโ€™re there? Can't remember that word on the tip of their tongue? Brain moving like it's stuck in molasses?

Research shows this issue usually starts hitting research subjects in their 40s and 50s. But here's the good news: it's not the brain "breaking down."

What's actually happeningโ€ฆ

>The brain's dealing with:
> Inflammation
> Messed-up metabolism
> Terrible sleep
> Not enough mental challenges

๐Ÿ–ฅ๐Ÿ–ฅ๐Ÿ–ฅ Think of it like a computer running too many programs at once.

The cool part? Studies show you can literally train your RSโ€™s brain to work better.

๐Ÿง  Memory can improve.
๐Ÿง  Focus can sharpen.
๐Ÿง  Mental decline can slow down.

The brain has this superpower called neuroplasticity - basically, it can rewire itself at any age.

Certain research compounds like DIHEXA are called "neurotrophic" because they help the brain:

๐Ÿ”ฅ Build new connections
๐Ÿ”ฅ Fix damaged cells
๐Ÿ”ฅ Speed up how neurons talk to each other.

๐Ÿ”ฌ Dihexa Research Focus

Dihexa is a potent synaptogenic compound studied for neural connectivity and regeneration in research models.

Research shows Dihexa promotes formation of new synapses and enhances neuroplasticity. Animal studies demonstrate reversal of cognitive deficits, working at growth factor signaling pathways.

๐Ÿ”ฌ Research Applications:
> Memory and learning studies
> Cognitive decline research models
> Neuroplasticity investigations
> Synaptic formation research

โš ๏ธ Research Considerations:
> Start with minimal doses in studies
> Monitor response in research subjects
> Not suitable for certain research models (pregnancy studies, seizure-prone subjects)

Research use only. Not for human or animal consumption.
โค1
NEW Substack post! Brain Fog and Memory Loss: Whatโ€™s Really Happening in Your 40s and 50s

Cognitive Enhancement Research in Neuroplasticity, Dihexa Nootropic, and Mind Health

https://primalsam.substack.com/p/brain-fog-and-memory-loss-whats-really
๐Ÿ’Š GLP-1 + GIP: Tablets vs Injections - Which delivery method for which research subjects?

Understanding the route of administration is critical for research outcomes. Here's the breakdown:

Injectable GLP-1 + GIP (like Tirzepatide):
โ†’ Higher bioavailability (100% reaches systemic circulation)
โ†’ Predictable pharmacokinetics
โ†’ Once-weekly dosing in most research protocols
โ†’ More stable plasma concentrations
โ†’ Best for: Research requiring consistent, measurable levels
โ†’ Considerations: Requires proper injection technique, cold storage

Oral Tablets (GLP-1 + GIP):
โ†’ Lower bioavailability in some (absorption varies)
โ†’ Daily dosing required
โ†’ Easier administration for research subjects
โ†’ No injection site reactions to track
โ†’ Best for: Compliance-focused studies, needle-averse subjects
โ†’ Considerations: Food/timing interactions, variable absorption

Research Applications:
*Weight/metabolic studies โ†’ Injectable preferred for consistency
*Behavioral compliance studies โ†’ Oral may show real-world applicability
*Long-term research โ†’ Oral may improve subject retention
*Dose-response studies โ†’ Injectable provides cleaner data

Bottom line: Route selection should match your research objectives and subject population characteristics.

Research use only. Not for human or animal consumption.
โค1๐Ÿ”ฅ1
๐Ÿงช Biostrategix Tirz 1mg tablets - NEW and on sale!

Limited time: Save $35 plus an extra 10% on 1st orders with code PRIMALSAM

ORAL TIRZ: https://collabs.shop/puzf5g

Research peptides are for research use only, and not specified for human, animal, or in-vivo use.
๐Ÿ‘1
Mazdutide & Survodutide: The Liver-Hacking Upgrade


These two aren't playing the same game as Sema and Tirz. They're dual/triple agonists that bring a new player to the research fight: Glucagon.


Mazdutide (GLP-1/Glucagon Dual Agonist):


Think of this as Tirzepatide's more aggressive cousin.

While it still has the powerful GLP-1 effect to curb appetite, it also activates the glucagon receptor.


What does Glucagon activation do? It tells your subjectโ€™s liver to ramp up energy expenditure.

This means your RS starts burning more fat for fuel, essentially turning metabolism up. It's not just about eating less; it's about becoming a more efficient fat-burning machine 24/7.


The Result: Potentially superior fat loss, especially stubborn visceral fat, compared to GLP-1-only drugs.


Survodutide (GLP-1/Glucagon Dual Agonist):


This is the heavy artillery. It's specifically engineered with a strong bias towards the glucagon receptor. The focus here is direct fat oxidation.


The Liver is the Engine: Survodutide doesn't just politely ask the liver to burn fat; it commands it.


Clinical trials are showing staggering weight loss results that are competing with, and in some cases surpassing, the current leaders.


The Result: This is for when your RS has significant weight to lose or has hit a wall with other peptides.


It attacks the problem from both ends: crushing appetite and forcibly accelerating baseline metabolism.


Why This Matters:


Your RS is not just trying to feel less hungry, but trying to reshape the body. Adding a potent glucagon component means pharmacologically hacking metabolism to work in your subjectโ€™s favor.
๐Ÿฅฐ1
Mazdutide
https://collabs.shop/zm8cjq

Use code PRIMALSAM for 10% off your order!

*Research peptides are for research use only, and not specified for human, animal, or in-vivo use.
๐Ÿ”ฅ1
Survodutide
https://collabs.shop/utvi15

Use code PRIMALSAM for 10% off your order!

*Research peptides are for research use only, and not specified for human, animal, or in-vivo use.
โค1
๐Ÿ”ฌ What happens when you combine BPC-157 with TB-500?

These two compounds are frequently studied together in regenerative research because they work better as a team.

How BPC-157 works in research models:
โ†’ Promotes new blood vessel formation
โ†’ Supports collagen production
โ†’ Activates growth factor signals
โ†’ Reduces inflammatory responses

How TB-500 (Thymosin Beta-4) works in research models:
โ†’ Helps cells move and develop
โ†’ Supports tissue rebuilding
โ†’ Activates natural repair processes
โ†’ Enhances structural protein formation

What researchers study them for:
โ†’ Soft tissue injury models
โ†’ Post-surgical recovery studies
โ†’ Chronic injury research
โ†’ Muscle and joint repair investigations
โ†’ Inflammation response studies

Why they work well together in research:

Research shows the combination creates faster tissue repair, better blood vessel development, stronger healed tissue, lower inflammation markers, and improved mobility outcomes in study models.

Think of it like this:

BPC-157 builds the roads (blood vessels and connective tissue) while TB-500 helps the construction crew get where they need to go (cell migration and organization). Together, they cover more ground.

Research use only. Not for human or animal consumption.
โค1
๐ŸŽ‰ My research subject can ACTUALLY say it's lost 35 whole pounds!

After hitting a frustrating stall, the breakthrough came from splitting GLP-1 injx into 4 micro-doses throughout the week instead of 2.

Same total amount, just spread out differently.

This is week 2 of this protocol adjustment, but the scale is STILL going down! Slowly but surely ๐Ÿ’ช

The full research protocol that contributed (bc we canโ€™t ignore the other foundations, yo):

โ†’ Stacking GLP-1 peptides + cycling supportive compounds
โ†’ Addressing deeper gut and histamine root causes (more on that soon)
โ†’ Adding HRT protocols (including testosterone injx)
โ†’ Switching thyroid support from synthetic combo back to NDT
โ†’ Moderate protein ancestral diet
โ†’ Primal lifestyle factors

๐Ÿ”ฅ But it was the micro-dosing adjustment that finally moved the needle after everything else plateaued.

Biohacking flexibility for the win, honey.

Have you found any success with your RS by splitting up doses further?

Research use only, not medical advice
โค1
โš ๏ธ ALERT: Testing Lab Shutdowns

We're hearing reports that peptide purity testing labs are being shut down, with at least one confirmed DEA raid.

What we know:
Forever Young Labs was recently raided and shut down
Client samples were confiscated
Clients have been redirected to LuxeN Health
At least one other California-based testing lab has experienced similar issues
Some researchers are now using Freedom Diagnostics

Why this matters:
Big pharma appears to be shifting tactics. Since they can't stop the grey market directly, they're targeting the testing infrastructure that verifies product quality and purity.

This is particularly concerning because:
These labs provide crucial quality assurance for researchers
Without third-party testing, researchers have no way to verify purity
This directly impacts research safety

What you can do:
Verify your current testing lab is still operational before sending samples
Have backup testing options identified
Document your testing protocols and results
Share information about operational labs you've successfully used recently

Important reminder:
Legal pressure continues to mount across the research industry. Stay informed. Stay safe. Please share updates if you have relevant information.

-Sam
From the desk of Hunter Williams:

" โ€œHunter, I see a ton of influencers now saying that itโ€™s better to (research) retatrutide once per week instead of microdosing. Iโ€™ve (researched) microdosing to great effect but am I messing up by not doing one big shot once per week?โ€

I actually received several questions like this in my question box over the past week.

In clinical trials, research has only examined once-per-week dosing of tirzepatide and retatrutide, so I understand the confusion.

Nonetheless, what matters most is how your (RS) handles the total weekly exposure and how your (RS's) metabolism responds to it.

Retatrutide is one of the most impressive tools ever created for metabolic repair and fat loss, but everyoneโ€™s (research) protocol will likely be different.

Some (subjects) do well with the standard weekly injection, while others feel miserable and perform far better when they divide their doses into smaller and more frequent injections."